NYSE:ZBH Zimmer Biomet (ZBH) Stock Price, News & Analysis $96.18 -1.27 (-1.30%) As of 11:00 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Zimmer Biomet Stock (NYSE:ZBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Zimmer Biomet alerts:Sign Up Key Stats Today's Range$95.71▼$97.2250-Day Range$87.98▼$101.4152-Week Range$79.12▼$103.70Volume252,544 shsAverage Volume2.22 million shsMarket Capitalization$18.34 billionP/E Ratio23.39Dividend Yield1.00%Price Target$104.47Consensus RatingHold Company Overview Zimmer Biomet Holdings, Inc. is a medical technology company that develops and manufactures products used in orthopedic surgery and musculoskeletal care. Its portfolio includes implants for the hip, knee, shoulder, and other joints, as well as products for sports medicine, extremity reconstruction, trauma, and spine procedures. The company also offers surgical technologies and solutions designed to support orthopedic procedures, including robotic-assisted surgery systems, digital tools, patient-specific planning, and related instruments. Zimmer Biomet sells its products to hospitals, ambulatory surgery centers, and healthcare professionals in markets around the world. Founded in 1927 by Justin O. Zimmer, the company is headquartered in Warsaw, Indiana, a center of the U.S. orthopedic device industry. Zimmer Biomet operates internationally and serves healthcare providers and patients across North America, Europe, Asia-Pacific, and other global markets. Ivan Tornos has served as the company's president and chief executive officer since 2023.AI Generated. May Contain Errors. Read More Zimmer Biomet Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreZBH MarketRank™: 3.956741354745 of 5 starsZimmer Biomet scored higher than 79% of companies evaluated by MarketBeat, and ranked 471st out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingHold Consensus RatingZimmer Biomet has received a consensus rating of Hold. The company's average rating score is 2.26, and is based on no strong buy ratings, 7 buy ratings, 15 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for Zimmer Biomet is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageZimmer Biomet has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Zimmer Biomet's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth5.15% Earnings GrowthEarnings for Zimmer Biomet are expected to grow by 5.15% in the coming year, from $8.54 to $8.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Zimmer Biomet is 23.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.21.Price to Earnings Ratio vs. SectorThe P/E ratio of Zimmer Biomet is 23.69, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.96.Price to Earnings Growth RatioZimmer Biomet has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioZimmer Biomet has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Zimmer Biomet's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.23% of the float of Zimmer Biomet has been sold short.Short Interest Ratio / Days to CoverZimmer Biomet has a short interest ratio ("days to cover") of 3.94, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Zimmer Biomet has recently decreased by 18.33%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldZimmer Biomet has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthZimmer Biomet does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Zimmer Biomet is 23.36%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Zimmer Biomet will have a dividend payout ratio of 10.69% next year. This indicates that Zimmer Biomet will be able to sustain or increase its dividend.Read more about Zimmer Biomet's dividend. News and Social Media2.7 / 5News Sentiment0.26 News SentimentZimmer Biomet has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Zimmer Biomet this week, compared to 5 articles on an average week.MarketBeat Follows4 people have added Zimmer Biomet to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Zimmer Biomet insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $824,028.00 in company stock.Percentage Held by Insiders1.28% of the stock of Zimmer Biomet is held by insiders.Percentage Held by Institutions88.89% of the stock of Zimmer Biomet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Zimmer Biomet's insider trading history. Receive ZBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZBH Stock News HeadlinesArthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint PainOctober 26 at 1:16 PM | prnewswire.comZimmer Biomet India Launches ROSA® Knee with OptimiZe™ in India to Advance Personalized Robotic-Assisted Knee ReplacementOctober 26 at 8:14 AM | finance.yahoo.com80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports to the U.S. With a January 1, 2027 deadline approaching, the Pentagon selected four companies to build critical mineral processing facilities on U.S. military bases. Only one was chosen for heavy rare earths - a Nasdaq-listed firm with an Ohio metallurgy facility under Pentagon contracts and rights to 80% of output from a major Canadian processing plant.October 27 at 1:00 AM | The Tomorrow Investor (Ad)Zimmer Biomet (NYSE:ZBH) Stock Rating Reaffirmed as "Buy" by ArgusOctober 24 at 2:01 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO) and Zimmer Biomet Holdings (ZBH)October 23, 2026 | theglobeandmail.comHere's what to expect from Zimmer Biomet's next earnings reportOctober 23, 2026 | msn.comZimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Now Rated "Hold" by Wall Street AnalystsOctober 22, 2026 | americanbankingnews.comZimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gainsOctober 21, 2026 | marketwatch.comSee More Headlines ZBH Stock Analysis - Frequently Asked Questions How have ZBH shares performed this year? Zimmer Biomet's stock was trading at $89.94 at the start of the year. Since then, ZBH stock has increased by 8.2% and is now trading at $97.36. How were Zimmer Biomet's earnings last quarter? Zimmer Biomet Holdings, Inc. (NYSE:ZBH) announced its earnings results on Wednesday, August, 5th. The medical equipment provider reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $2.01 by $0.06. The company's revenue was up 4.8% compared to the same quarter last year. Read the conference call transcript. Does Zimmer Biomet have any subsidiaries? Zimmer Biomet subsidiaries include Respondwell, Clinical Graphics, CD Diagnostics, Medtech SAS, Compression Therapy Products, LDR Holding, Cayenne Medical, and others. Who are Zimmer Biomet's major shareholders? Zimmer Biomet's top institutional shareholders include Leeward Investments LLC MA (0.05%), Hourglass Capital LLC (0.04%), Nisa Investment Advisors LLC (0.02%) and Uncommon Cents Investing Inc (0.02%). Insiders that own company stock include Chad F Phipps, Sang Yi and Lori Winkler. View institutional ownership trends. How do I buy shares of Zimmer Biomet? Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Zimmer Biomet own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zimmer Biomet investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), Pfizer (PFE), Salesforce (CRM), Walt Disney (DIS), Intel (INTC) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 7/31 Dividend6/25/2026Ex-Dividend for 7/31 Dividend6/25/2026Dividend Payable7/31/2026Last Earnings8/05/2026Record date for 10/30 Dividend9/30/2026Ex-Dividend for 10/30 Dividend9/30/2026Today10/27/2026Dividend Payable10/30/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, ZBH's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:ZBH Previous SymbolNYSE:ZMH CIK1136869 Webwww.zimmerbiomet.com Phone(574) 267-6131Fax574-372-4988Employees17,000Year Founded1927Price Target and Rating Average Price Target for Zimmer Biomet$104.47 High Price Target$125.00 Low Price Target$90.00 Potential Upside/Downside+8.9%Consensus RatingHold Rating Score (0-4)2.26 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)$4.11 Trailing P/E Ratio23.41 Forward P/E Ratio11.23 P/E Growth2.37Net Income$705.20 million Net Margins9.48% Pretax Margin10.97% Return on Equity13.12% Return on Assets7.23% Debt Debt-to-Equity Ratio0.50 Current Ratio1.69 Quick Ratio0.94 Sales & Book Value Annual Sales$8.51 billion Price / Sales2.15 Cash Flow$13.38 per share Price / Cash Flow7.17 Book Value$64.11 per share Price / Book1.50Miscellaneous Outstanding Shares190,738,000Free Float188,297,000Market Cap$18.30 billion OptionableOptionable Beta0.49 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NYSE:ZBH) was last updated on 10/27/2026 by MarketBeat.com Staff. From Our PartnersTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zimmer Biomet Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zimmer Biomet With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
